Table of Contents
Handling cytotoxic and hazardous drugs requires strict adherence to safety guidelines to protect healthcare workers and patients. The United States Pharmacopeia (USP) USP 797 provides comprehensive standards for sterile compounding, including specific protocols for managing these dangerous substances.
Understanding USP 797
USP 797 outlines procedures to ensure the quality, safety, and efficacy of compounded sterile preparations (CSPs). It emphasizes minimizing contamination, protecting personnel, and maintaining environmental controls. Special provisions are included for handling cytotoxic and hazardous drugs due to their inherent risks.
Key Principles for Safe Handling
- Personal Protective Equipment (PPE): Use appropriate PPE such as gloves, gowns, eye protection, and masks to prevent exposure.
- Engineering Controls: Utilize biological safety cabinets (BSCs) or compounding aseptic isolators (CAIs) to contain hazards.
- Environmental Controls: Maintain ISO Class 5 environments within ISO Class 7 buffer rooms.
- Training and Competency: Ensure all personnel are trained in handling hazardous drugs and follow USP 797 protocols.
Preparation and Handling Procedures
Proper procedures are vital to prevent contamination and exposure when preparing cytotoxic and hazardous drugs. These include:
- Performing all compounding in a certified ISO Class 5 environment.
- Using closed-system drug transfer devices (CSTDs) to minimize aerosolization.
- Following strict aseptic techniques during preparation.
- Labeling all hazardous drugs clearly with appropriate warnings.
Disposal and Decontamination
Proper disposal of hazardous waste and decontamination of work surfaces are essential to prevent environmental contamination and personnel exposure. Follow these guidelines:
- Use approved hazardous waste containers for disposal.
- Decontaminate work surfaces with EPA-registered disinfectants after each use.
- Follow local regulations for hazardous waste management.
Training and Compliance
Regular training ensures that staff are aware of the latest safety protocols and USP 797 updates. Compliance audits and continuous education help maintain high safety standards in handling cytotoxic and hazardous drugs.
Conclusion
Adhering to USP 797 guidelines for the safe handling of cytotoxic and hazardous drugs is crucial for protecting healthcare workers and patients. Proper environmental controls, PPE, training, and disposal practices form the foundation of a safe compounding environment.